European Pharmaceutical Review

OCTOBER 5, 2022

According to the survey, apprentice numbers are three times higher than 2015 statistics, across all skill levels from those entering the industry to master-qualified individuals. Pharmaceutical companies who contributed to the survey include AbbVie, AstraZeneca, Boehringer Ingelheim and GSK.

Pharma 104

Pharma Training Networking Pharmaceutical 104

Integrity Solutions

JULY 31, 2024

Today, amid market volatility, changing customer expectations and heightened competition, it’s more important than ever. employees are either watching for or actively seeking a new job — the highest level since 2015. Especially in a tight job market, talented salespeople are one of your biggest competitive differentiators.

Sales 171

Sales Management Training Product Knowledge 171

Sales Talent

FEBRUARY 7, 2020

As there isn’t a hiring forecast specific for b2b sales roles, we started our own forecast in 2015 to help fill this gap. It also means that employers face the most competitive, candidate-driven employment market in history. **The 2022 Sales Hiring Forecast has been released – check it out now!**. 2019 Sales Hiring in Review.

Sales 130

Sales B2B Sales Recruitment Marketing 130

Pharmaceutical Technology

NOVEMBER 22, 2022

China will continue to take steps towards becoming as competitive in high-value innovative pharma as it is in the generics industry, with The Wall Street Journal reporting Chinese biotechs raised $1.6tn through 568 venture financings last year, up from $11bn in 418 deals in 2020.

Manufacturing 64

Manufacturing Pharma Government FDA 64

Pharmaceutical Technology

DECEMBER 22, 2022

According to the National Institute of Drug Abuse, the total number of drug-involved overdose deaths in the US increased from 52,404 in 2015 to 91,799 in 2020. The drug’s extraordinary potency makes it much easier for a consumer to fatally overdose. A dangerous future.

Safety 105

Safety Manufacturing Distribution Prescription 105

European Pharmaceutical Review

JANUARY 31, 2025

By the end of the decade, two cell and gene therapies will be subject to follow-on competition for the first time, beginning a whole new chapter in the biosimilar history. Over time, patient volumes (patient treatment days) and levels of competition, including market share, were also considered. 6 billion in 2024 alone).

Medicine 52

Medicine Competition Marketing Patients 52

European Pharmaceutical Review

DECEMBER 14, 2023

Observational studies should not be seen as competition to RCTs but as complementary to them, and as a sector we need to stop working in silos and develop an integrated and more comprehensive approach to evidence-based decision-making in safeguarding public health. Guide on Methodological Standards in Pharmacoepidemiology (Revision 11).

Medicine 116

Medicine Safety Competition Medical 116

pharmaphorum

SEPTEMBER 21, 2022

Novartis is running out of options in its bid to defend oral muscular sclerosis therapy Gilenya from early generic competition in the US. 9,187,405, granted in 2015, which covers a specific dosing regimen for Gilenya (fingolimod) in relapsing-remitting MS. Gilenya made revenues of $2.8

Competition 52

Competition Pharma Sales Marketing 52

pharmaphorum

JULY 27, 2022

Latest UK Life Sciences Competitive Indicators “ought to ring alarm bells across Government,” says ABPI. Richard Torbett, chief executive at the Association of the British Pharmaceutical Industry (ABPI) said Life Sciences Competitive Indicators (LSCI) data published last week “ought to ring alarm bells across Government”.

Government 98

Government Recruitment Medicine Patients 98

pharmaphorum

OCTOBER 10, 2022

Teva’s last remaining Copaxone (glatiramer acetate) patent expired in Europe in February 2015 and the Commission said last March it was investigating whether the company acted lawfully in trying to delay the entry of lower-cost generic versions of the drug.

Competition 52

Competition Marketing Medicine Pharma 52

Clarivate

FEBRUARY 10, 2022

For this report on innovation in South and Southeast Asia, we analyzed patents filed from 2015 to 2019 by organizations headquartered in this region. To better understand the key players and the emerging, evolving trends in innovation, we looked across the South and Southeast Asia landscape in our latest report. Measuring innovation.

Government 52

Government Competition Engineering Manufacturing 52

pharmaphorum

OCTOBER 17, 2022

Novartis’ hopes that the Supreme Court would protect its big-selling multiple sclerosis drug Gilenya from generic competition have been dashed. 9,187,405, granted in 2015, which comes to an end in 2027. If they do so, Novartis has predicted it will lose $300 million in sales over the remainder of this year.

Competition 52

Competition Marketing Sales Pharma 52

Clarivate

JUNE 23, 2022

Analyzing historical trends for the past 10 years reveals that the number of Indian paragraph IV filers continues to grow, while the number of filers in the United States has been stable since 2015. While Mainland China has only been involved in paragraph IV filings since 2015, this volume is increasing significantly.

Distribution 52

Distribution Marketing Competition Medicine 52

European Pharmaceutical Review

APRIL 11, 2024

Globally, the pharmaceutical sector emitted around 52 megatonnes of CO 2 in 2015, the most recent period for which detailed numbers are available. Creating more sustainable business processes is a pre-competitive activity; we all win when we make progress in sustainability and lose if we don’t.

Manufacturing 105

Manufacturing Pharmaceutical Engineering Pharmaceutical manufacturing 105

Pharmaceutical Technology

MARCH 24, 2023

Biosimilars are an important tool to facilitate competition, lower the price of drugs, and create savings across the board. Until 2010, no regulatory approval pathway for biosimilars existed in the US and the first biosimilar was only approved in the US in 2015. The biosimilar market in the US may progress differently this time.

Competition 59

Competition Marketing FDA Physicians 59

Pharmaceutical Technology

JULY 25, 2022

But this also means potentially stiffer competition for chemical entities and small molecules in comparison to biosimilars, states Vasquez. Copaxone first went generic in 2015 , sold under the name Glatopa by Novartis’s subsidiary Sandoz. while Sandoz’s generic is sold for $6,492.41.

Manufacturing 119

Manufacturing Marketing Pharmaceutical FDA 119

European Pharmaceutical Review

OCTOBER 19, 2022

2 Recently, the US Patent and Trademark Office (US PTO) reiterated the concern that patents have been “misused to inhibit and delay – for years and even decades – competition from generic drugs and biosimilars, denying Americans access to lower-cost drugs.” Patents are often described as the ‘lifeblood’ of pharmaceutical companies.

Food and Drug Administration 96

Food and Drug Administration Pharmaceutical products Pharmaceutical FDA 96

Impetus Digital

MARCH 15, 2024

Increased competition and evolving standard of care New competitors are entering the market at a rapid pace, and competition is intensifying. This competitive intensity tends to focus on smaller patient populations with multiple treatment options (1,2). However, with rapid growth comes growing pains.

Recruitment 78

Recruitment Patients Healthcare Provider Healthcare 78

Pharmaceutical Technology

SEPTEMBER 26, 2022

Strong competition limits Sandoz's growth. Sandoz has faced and may in the future face strong competition from other generic and biosimilar pharmaceutical companies, which aggressively compete for market share, including through significant price competition. The site employs around 250 people.

Competition 64

Competition Manufacturing Marketing Distribution 64

Spotio

FEBRUARY 21, 2023

The goals are to increase quality, decrease costs and turn health care into a competitive marketplace. They cite a 24% increase in drug costs per hospital admission in 2014 and a 12% increase in 2015. Healthcare as a competitive market is a new idea. Expect short term upheaval and long term economic impacts.

Medical sales 52

Medical sales Sales Medical Physicians 52

European Pharmaceutical Review

AUGUST 23, 2022

Article 15 proved that transparent and effective assessments of new technologies were crucial to ensure fair competition between stakeholders that operate in the EU. As mentioned, the full extent of the long-term effects is not yet foreseeable, however the authors are of the opinion that at least one pro and one con are apparent.

Consulting 98

Consulting Medical Healthcare Healthcare 98

pharmaphorum

JULY 15, 2022

Teva launched its first generic in that year with a skinny label that excluded the heart failure use, as it was covered by a use patent that expired in 2015. The substance patent expired in 2007. The post Teva asks SCOTUS to overturn “skinny label” verdict on GSK drug appeared first on.

Prescription 52

Prescription Marketing Doctors Government 52

pharmaphorum

JANUARY 16, 2023

Ageing will only compound the challenge: high income country populations are already old, but between 2015 and 2050, the proportion of the world’s population aged over 60 will nearly double, from 12% to 22%, and, by 2050, 80% of older people will be living in low- and middle-income countries. About the author.

FDA 98

FDA Healthcare Healthcare Medicine 98

Evolve Your Success

MAY 23, 2023

With VR simulations, sales reps can now hone their skills in lifelike scenarios, giving them a competitive edge in the field. Around 2014 and 2015, Oculus launched a kick-starter campaign and created the first mass-market VR headset. I landed this competitive scholarship at the National Cancer Institute at school.

Training 130

Training Sales Medical Medical sales 130

European Pharmaceutical Review

DECEMBER 21, 2022

16,17 However, care must be taken to ensure that chemicals from biomass are not produced in competition with food production and do not have a negative impact on the environment or natural habitats. In 2015 he joined the Process Chemistry & Catalysis group at F. Green Chem 2015, 17, 123‒145. Kralisch D, Otta D, Gericke D.

Manufacturing 97

Manufacturing Pharmaceutical Healthcare Healthcare 97

MedCepts

NOVEMBER 7, 2017

And along came some competition – facebook, twitter, google+, linkedin…. In 2015, we performed a case study of the Impact of Social Media on website rankings. In addition, consider the time you’re investing – particularly if you are primarily focused on one site. Do you remember when MYSPACE was king of the hill?

Networking 52

Networking Medical Healthcare Healthcare 52

PM360

AUGUST 9, 2022

Then between 2005-2015, there were 110 global blockbuster launches, with a high concentration in specialty care and biologics. ZS’ research tracking launches from 2015-2020 shows that novel product launches are just as likely to underperform as overperform (see Figure 1). Ask: Is this component truly a competitive advantage?

Biopharma 69

Biopharma Marketing Healthcare Healthcare 69

Healthcare Success

MAY 3, 2021

Depending on your source, a typical generational breakdown lists society as five slices: Gen Z, iGen, or Centennials: Born 1996 – 2015 Millennials or Gen Y: Born 1977 – 1995 Generation X: Born 1965 – 1976 Baby Boomers: Born 1946 – 1964 Traditionalists or Silent Generation: Born 1945 and before.

Distribution 90

Distribution Marketing Healthcare Healthcare 90

Clarify Health

MARCH 27, 2023

Users can also compare sourced rates across services, providers, and payers in any given market to quickly receive insight on their competitive negotiated rate standing against their peers. “Well organized price transparency data creates a new and essential category of business intelligence across the industry.

Engineering 52

Engineering Healthcare Healthcare Marketing 52

Healthcare Success

JUNE 13, 2022

Here are four personalized healthcare marketing strategies you can employ to stay competitive: 1. According to a 2015 study by Pew Research Center, 62% of Americans looked for health information on mobile devices. Post-Admission Engagement. Developing a robust plan for follow-up care (e.g., Today, that figure is likely much higher.

Healthcare 95

Healthcare Healthcare Marketing Patients 95

Clarify Health

AUGUST 22, 2023

Alternative payment models were introduced as part of the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA). To ensure they remain competitive in an increasingly crowded healthcare payer field, executives should continue to explore and invest in alternative payment models. What are alternative payment models?

Healthcare 52

Healthcare Healthcare Patients Physicians 52

PM360

MAY 15, 2023

For example, starting in 2015 at Ogilvy, I watched companies that had been using print materials in doctors’ offices begin switching to large electronic tablets in waiting and exams rooms that displayed information for multiple brands.

Marketing 52

Marketing Electronics Doctors Physicians 52

Celeritas

FEBRUARY 24, 2023

Say hello to your competition. 2015 Jan;56(1):89-92. “The 7 years you spend here as a surgical resident will be the best and worst of your life,” it says, “You will be pushed to the breaking point. Look around you. Eight of you will switch to an easier specialty. Five of you will crack under the pressure. This is your arena.”

Management 52

Management Consulting Doctors Education 52

CloserIQ

OCTOBER 10, 2018

Founded 2015. Cybereason’s workplace culture is known to be fast-paced and competitive, with plenty of opportunities for learning. Salsify offers competitive benefits and a flexible vacation plan. Employees praise the company for its strong sense of mission and commitment to improving education. 6 River Systems. See open roles.

Sales 76

Sales Management Marketing Education 76

MedCepts

NOVEMBER 7, 2017

Unique, relevant and quality content will provide the medical and healthcare related business a competitive edge. The image above reflects nearly 3,000 retweets and favorites from a single post (tweet) we did on January 20, 2015. Quality content results in increased website traffic and improved SEO (Search Engine Optimization).

Healthcare 52

Healthcare Healthcare Medical Distribution 52

Clarivate

APRIL 24, 2023

After Walgreens upped its ownership stake in the primary-care company VillageMD from 30 to 63 percent and then announced plans to operate 1,000 clinics by 2027, the writing was on the wall: to stay competitive and manage costs in CVS’ newly integrated Aetna plan, CVS could benefit by making a larger bid for primary care of its own.

Healthcare 89

Healthcare Healthcare Marketing Physicians 89

Pharmaceutical Technology

OCTOBER 25, 2022

Understanding both the significant competitive advantages that FDC products can offer, and the difficulties and potential pitfalls associated with development and manufacturing of FDC drugs in oral solid dosage forms is a critical first step for companies exploring this approach. Of those 131 approved FDCs, 98 were oral dosage forms.

Manufacturing 52

Manufacturing Physicians Prescription Pharmaceutical 52